This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bristol-Myers Squibb To Announce Results For Third Quarter 2013 On October 23

First graph, second sentence of release dated Oct. 1, 2013 should read: During a conference call at 10 a.m. ET (sted During a conference call at 9 a.m. ET).

The corrected release reads:

Bristol-Myers Squibb to Announce Results for Third Quarter 2013 on October 23

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the third quarter of 2013 on Wednesday, October 23, 2013. During a conference call at 10 a.m. ET on October 23, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at www.bms.com/investors or by dialing 913-981-5509, confirmation code: 4094914. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. ET on October 23 through midnight ET on November 6, 2013. The replay will also be available through www.bms.com/investors or by dialing 402-280-9013, confirmation code: 4094914.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs